Klinefelter syndrome US Medical PG Practice Questions and MCQs
Practice US Medical PG questions for Klinefelter syndrome. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Klinefelter syndrome US Medical PG Question 1: A 16-year-old presents to the primary care physician because he has noticed an increase in the size of his breast tissue over the past 3 years. He states that he is significantly taller than his entire class at school although he feels increasingly weak and uncoordinated. He performs at the bottom of his grade level academically. On physical exam the patient has marked gynecomastia with small firm testes. The physician decides to perform a karyotype on the patient. What is the most likely outcome of this test?
- A. 47, XYY
- B. 45, XO
- C. 47, XXY (Correct Answer)
- D. 47, XXX
- E. 46, XY
Klinefelter syndrome Explanation: ***47, XXY***
The constellation of **gynecomastia, tall stature, learning difficulties, and small testes** is classic for **Klinefelter syndrome**, which is characterized by a **47, XXY** karyotype.
The presence of an extra X chromosome leads to **hypogonadism** and **endocrine imbalances**, explaining the physical and developmental findings.
*47, XYY*
- Individuals with **47, XYY syndrome** are typically tall but do not usually present with breast enlargement or other features of hypogonadism.
- They may have an increased risk of learning difficulties and behavioral problems.
*45, XO*
- This karyotype, also known as **Turner syndrome**, is characterized by the absence of an X chromosome and typically affects **females**.
- Common features include **short stature, webbed neck, and ovarian dysfunction**, which are inconsistent with the patient's presentation.
*47, XXX*
- This karyotype, known as **Triple X syndrome**, affects **females** and is characterized by the presence of an extra X chromosome.
- While some individuals may experience learning difficulties or developmental delays, it does not cause gynecomastia or small testes in males.
*46, XY*
- This is the **normal male karyotype** and would not explain the patient's symptoms of gynecomastia, small testes, tall stature, or learning difficulties.
- These symptoms suggest an underlying chromosomal abnormality.
Klinefelter syndrome US Medical PG Question 2: A 19-year-old male from rural West Virginia presents to his family medicine doctor to discuss why he is having trouble getting his wife pregnant. On exam, he is 6 feet 2 inches with a frail frame and broad hips for a male his size. He is noted to have mild gynecomastia, no facial hair, and small, underdeveloped testes. He claims that although he has a lower libido than most of his friends, he does have unprotected sex with his wife. His past medical history is notable for developmental delay and difficulties in school. What is the most likely chromosomal abnormality in this patient?
- A. Trisomy 13
- B. 45: XO
- C. Trisomy 21
- D. 47: XYY
- E. 47: XXY (Correct Answer)
Klinefelter syndrome Explanation: ***47: XXY***
- The patient's presentation with **infertility**, small testes, **gynecomastia**, eunuchoid body habitus (tall, frail frame, broad hips), lack of facial hair, and **developmental delay** are classic features of **Klinefelter syndrome (47, XXY)**.
- This chromosomal abnormality leads to primary **hypogonadism** due to the presence of an extra X chromosome in males.
*Trisomy 13*
- Trisomy 13, or **Patau syndrome**, is characterized by severe developmental anomalies, including **cleft lip and palate**, polydactyly, and severe neurological defects.
- Infants with Trisomy 13 rarely survive beyond the first year and do not present with the described signs of hypogonadism or gynecomastia in adolescence.
*45: XO*
- **45, XO** or **Turner syndrome** affects females and is characterized by **short stature**, primary amenorrhea, webbed neck, and **gonadal dysgenesis (streak gonads)**.
- This karyotype is incompatible with a male phenotype and the symptoms described.
*Trisomy 21*
- Trisomy 21, or **Down syndrome**, is associated with distinct facial features, intellectual disability, and congenital heart defects.
- While individuals with Down syndrome may have fertility issues, they do not typically present with the specific combination of **gynecomastia**, eunuchoid habitus, and **small testes** seen in this patient.
*47: XYY*
- **47, XYY syndrome** is associated with increased height and potentially some learning difficulties, but typically does not cause the significant **hypogonadism**, **gynecomastia**, or **small testes** seen in this patient.
- Men with 47, XYY usually have normal sexual development and fertility, though some may experience learning disabilities or behavioral problems.
Klinefelter syndrome US Medical PG Question 3: A 14-year-old boy is brought to the physician by his parents for a well-child visit. The patient was born at 38 weeks' gestation via vaginal delivery and has been healthy. He attends a junior high school and is having difficulties keeping up with his classmates in many classes. He is at the 97th percentile for height and 50th percentile for weight. Vital signs are within normal limits. Cardiac examination shows a high-frequency midsystolic click that is best heard at the left fifth intercostal space. The patient has long extremities along with excess breast tissue bilaterally. He has no axillary hair. Genital examination shows reduced scrotal size and a normal sized penis. Which of the following tests is the most likely to diagnose the patient's underlying disorder?
- A. Urinalysis
- B. Southern blot
- C. Slit-lamp examination
- D. Karyotyping (Correct Answer)
- E. Serum IGF-1 measurement
Klinefelter syndrome Explanation: ***Karyotyping***
- The patient's presentation with **tall stature**, **long extremities**, **gynecomastia**, **small testes**, and **learning difficulties** is highly suggestive of **Klinefelter syndrome (47,XXY)**.
- **Karyotyping** is the definitive diagnostic test for Klinefelter syndrome as it identifies the presence of an extra X chromosome.
*Urinalysis*
- This test is used to detect various kidney and urinary tract conditions and would not identify a **chromosomal abnormality**.
- While it can reveal issues like **proteinuria** or **hematuria**, these are not consistent with the primary presenting symptoms.
*Southern blot*
- This technique detects specific **DNA sequences** and is used for conditions like **fragile X syndrome** or **gene deletions**, but it is not the primary diagnostic tool for **aneuploidies** like Klinefelter syndrome.
- Karyotyping provides a broader overview of the entire **chromosome set**, which is necessary to identify an extra chromosome.
*Slit-lamp examination*
- This examination is used to visualize the eyes and is relevant for conditions like **Marfan syndrome** (**ectopia lentis**) or other ocular abnormalities, which are not the primary concern here.
- There are no symptoms presented that would suggest the need for a **slit-lamp examination**.
*Serum IGF-1 measurement*
- **Insulin-like growth factor 1 (IGF-1)** is measured to assess **growth hormone levels** and diagnose conditions like **acromegaly** or **dwarfism**.
- While the patient is tall, his other features (gynecomastia, small testes, learning difficulties) point strongly to a **chromosomal disorder** rather than a primary growth hormone abnormality.
Klinefelter syndrome US Medical PG Question 4: A 17-year-old female presents to her pediatrician due to lack of menstruation. She states that she developed breasts 4 years ago but has not experienced menses yet. The patient denies abdominal pain and has no past medical history. Her mother underwent menarche at age 13. The patient is a volleyball player at school, is single, and has never attempted intercourse. At this visit, her temperature is 98.3°F (36.8°C), blood pressure is 110/76 mmHg, pulse is 72/min, and respirations are 14/min. She is 5 feet 7 inches tall and weighs 116 pounds (BMI 18.2 kg/m²). Exam shows Tanner IV breasts, Tanner I pubic hair, and minimal axillary hair. External genitalia are normal, but the vagina is a 5-centimeter blind pouch. Which of the following is the most appropriate initial diagnostic test?
- A. Obtain FSH and estrogen levels (Correct Answer)
- B. Vaginoplasty
- C. ACTH stimulation test
- D. Gonadectomy
- E. Estrogen replacement therapy
Klinefelter syndrome Explanation: ***Obtain FSH and estrogen levels***
- The patient presents with **primary amenorrhea**, breast development (Tanner IV), but absent pubic/axillary hair (Tanner I) and a blind pouch vagina. These findings are highly suspicious for **Androgen Insensitivity Syndrome (AIS)**.
- Measuring **Follicle-Stimulating Hormone (FSH)** and **estrogen levels** will help differentiate between causes of primary amenorrhea, particularly in cases of suspected gonadal dysfunction or end-organ unresponsiveness. Elevated FSH would suggest gonadal failure, while normal to high estrogen despite absent menses points towards hormonal unresponsiveness.
*Vaginoplasty*
- This is a surgical procedure to create or lengthen the vagina and is a **definitive treatment** for conditions like Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome or severe vaginal agenesis, but it is not an initial diagnostic step.
- Performing surgery without a clear diagnosis is inappropriate and premature, as the underlying cause of the blind vaginal pouch needs to be identified first.
*ACTH stimulation test*
- An **ACTH stimulation test** is used to diagnose **adrenal insufficiency** or **congenital adrenal hyperplasia (CAH)**.
- While CAH can cause ambiguous genitalia and primary amenorrhea in some forms, this patient has normal female external genitalia and breast development, making CAH less likely, and this test isn't the primary diagnostic step for her presentation.
*Gonadectomy*
- **Gonadectomy** is the surgical removal of gonads and is typically performed in individuals with certain **Disorders of Sex Development (DSDs)**, such as AIS with intra-abdominal testes, to prevent **gonadal malignancy**.
- This is a **treatment** measure, not a diagnostic test, and is only considered after a definitive diagnosis of the underlying condition.
*Estrogen replacement therapy*
- **Estrogen replacement therapy** might be considered as a treatment for **hypogonadism** or to induce secondary sexual characteristics in certain types of primary amenorrhea (e.g., gonadal dysgenesis).
- However, in a patient with breast development (Tanner IV), estrogen production is likely occurring, making it an inappropriate initial diagnostic choice or treatment, especially before determining the cause of amenorrhea.
Klinefelter syndrome US Medical PG Question 5: A 42-year-old woman, gravida 1, para 0, at 10 weeks' gestation comes to the physician for a prenatal examination. She has no history of significant medical illness. Physical examination shows a uterus consistent with a 10-week gestation. Cell-free fetal DNA testing shows a karyotype of 47,XXY. If the fetus's condition had not been diagnosed until puberty, which of the following sets of hormonal changes would most likely be found at that time?
$$$ Follicle-stimulating hormone %%% Luteinizing hormone %%% Testosterone %%% Estrogen $$$
- A. ↑ ↑ ↓ ↑ (Correct Answer)
- B. ↓ ↓ normal ↑
- C. ↑ ↑ normal normal
- D. ↓ ↓ ↓ ↓
- E. ↑ ↑ ↑ ↓
Klinefelter syndrome Explanation: ***↑ ↑ ↓ ↑***
- This hormonal pattern is characteristic of **Klinefelter syndrome (47,XXY)** at puberty, where testicular dysfunction leads to **primary hypogonadism**.
- **Decreased testosterone** due to impaired Leydig cell function causes **increased LH and FSH** (due to a lack of negative feedback), while aromatization of excess androgens in peripheral tissues results in **increased estrogen**.
*↓ ↓ normal ↑*
- This pattern (low FSH, low LH, normal testosterone, high estrogen) would suggest **secondary hypogonadism** or an estrogen-producing tumor, which is not consistent with Klinefelter syndrome.
- In secondary hypogonadism, the pituitary is the primary problem, leading to insufficient gonadotropin production; however, in Klinefelter, the problem is primarily testicular.
*↑ ↑ normal normal*
- While FSH and LH are elevated in Klinefelter syndrome, testosterone is typically *decreased*, not normal, and estrogen is often *increased*, not normal.
- This option does not fully capture the classic hormonal profile of **primary hypogonadism with feminization** seen in Klinefelter syndrome.
*↓ ↓ ↓ ↓*
- This pattern of universally low hormone levels is not typical for Klinefelter syndrome.
- Such widespread reduction in hormones might be seen in severe **panhypopituitarism**, which affects multiple endocrine axes and is a distinct condition.
*↑ ↑ ↑ ↓*
- While FSH and LH are elevated, and testosterone is decreased, estrogen is typically *increased* (due to peripheral conversion of androgens) in Klinefelter syndrome, not decreased.
- A decrease in estrogen along with elevated gonadotropins and decreased testosterone would indicate a different type of hormonal imbalance, possibly associated with **severe ovarian failure** if it were a female.
Klinefelter syndrome US Medical PG Question 6: A 15-year-old boy is brought to the physician by his mother for a well-child examination. He recently stopped attending his swim classes. The patient is at the 97th percentile for height and the 50th percentile for weight. Examination shows decreased facial hair, bilateral breast enlargement, and long extremities. Genital examination shows scant pubic hair, small testes, and a normal-sized penis. Further evaluation is most likely to show which of the following karyotypes?
- A. 45,XO/46,XX
- B. 45,XO
- C. 47,XYY
- D. 46,XX/46,XY
- E. 47,XXY (Correct Answer)
Klinefelter syndrome Explanation: ***47,XXY***
- The patient's presentation with **tall stature**, **gynecomastia**, **small testes**, and **scant pubic hair** is characteristic of **Klinefelter syndrome**, which is caused by a **47,XXY karyotype**.
- **Hypogonadism** in Klinefelter syndrome leads to **decreased testosterone production**, explaining the lack of facial hair and undeveloped secondary sexual characteristics.
*45,XO/46,XX*
- This mosaic karyotype is associated with **Turner syndrome**, which primarily affects females and presents with features like **short stature**, **gonadal dysgenesis**, and **webbed neck**.
- Males with this karyotype are rare and would not exhibit the typical features described, such as **gynecomastia** and eunuchoid body habitus.
*45,XO*
- This is the classic karyotype for **Turner syndrome**, which is exclusively found in phenotypic females.
- Individuals with 45,XO present with **short stature**, **streak gonads**, and a lack of secondary sexual characteristics, none of which align with the male patient's symptoms.
*47,XYY*
- Individuals with **XYY syndrome** (Jacob syndrome) are typically **tall** but usually have **normal sexual development** and **fertility**.
- This karyotype does not explain the **gynecomastia**, **small testes**, or **decreased facial hair** seen in the patient.
*46,XX/46,XY*
- This karyotype indicates **gonadal mosaicism**, also known as **ovotesticular disorder of sex development (DSD)** or **chimerism**, where an individual has both ovarian and testicular tissue.
- While it can present with ambiguous genitalia and mixed secondary sexual characteristics, the specific constellation of **tall stature**, **gynecomastia**, and **small testes** is more indicative of Klinefelter syndrome.
Klinefelter syndrome US Medical PG Question 7: A 41-year-old woman is referred by her radiation oncologist to the medical genetics clinic. She was recently diagnosed with an infiltrating ductal carcinoma of the breast. She has a previous history of colonic polyps for which she undergoes bi-annual colonoscopy. The maternal and paternal family history is unremarkable for polyps and malignant or benign tumors. However, the patient reports that her 10-year-old son has dark brown pigmentation on his lips, and she also had similar pigmentation as a child. Histology of colonic polyps in this patient will most likely reveal which of the following?
- A. Adenomatous polyps
- B. Inflammatory polyps
- C. Retention polyps
- D. Hyperplastic polyps
- E. Hamartomatous polyps (Correct Answer)
Klinefelter syndrome Explanation: ***Hamartomatous polyps***
- The constellation of **breast carcinoma**, a history of **colonic polyps**, and **mucocutaneous pigmentation** (dark brown pigmentation on lips in the patient and her son) is highly suggestive of **Peutz-Jeghers Syndrome**.
- **Peutz-Jeghers Syndrome** is an autosomal dominant disorder characterized by the development of **hamartomatous polyps** in the gastrointestinal tract and an increased risk of various cancers, including breast and colorectal cancer.
*Adenomatous polyps*
- While adenomatous polyps are common and can be a precursor to colorectal cancer, the presence of associated **mucocutaneous pigmentation** points away from typical adenomatous familial or sporadic polyposis syndromes (e.g., FAP).
- These polyps are characteristic of **Familial Adenomatous Polyposis (FAP)** or sporadic colorectal cancer, but FAP usually presents with hundreds to thousands of polyps and does not typically involve mucocutaneous pigmentation.
*Inflammatory polyps*
- **Inflammatory polyps** are typically a reactive process secondary to chronic inflammation, such as in inflammatory bowel disease (Crohn's disease or ulcerative colitis), and are not associated with specific hereditary syndromes like Peutz-Jeghers or mucocutaneous pigmentation.
- They do not carry the same increased risk of malignancy as hamartomatous or adenomatous polyps in the context of a syndrome.
*Retention polyps*
- **Retention polyps**, also known as juvenile polyps, are usually found in children and are typically benign; however, they can occur sporadically in adults.
- They are generally solitary or few in number and are not associated with the distinct syndromic features of mucocutaneous pigmentation or the wide range of cancer risks seen in Peutz-Jeghers syndrome.
*Hyperplastic polyps*
- **Hyperplastic polyps** are generally considered benign and do not typically lead to cancer, although some serrated hyperplastic polyps can have malignant potential.
- They are not associated with hereditary syndromes presenting with cutaneous pigmentation and multiple extracolic malignancies.
Klinefelter syndrome US Medical PG Question 8: A six-year-old male presents to the pediatrician for a well child visit. The patient’s parents report that they are struggling to manage his temper tantrums, which happen as frequently as several times per day. They usually occur in the morning before school and during mealtimes, when his parents try to limit how much he eats. The patient often returns for second or third helpings at meals and snacks throughout the day. The patient’s parents have begun limiting the patient’s food intake because he has been gaining weight. They also report that the patient recently began first grade but still struggles with counting objects and naming letters consistently. The patient sat without support at 11 months of age and walked at 17 months of age. He is in the 99th percentile for weight and 5th percentile for height. On physical exam, he has almond-shaped eyes and a downturned mouth. He has poor muscle tone.
Which of the following additional findings would most likely be seen in this patient?
- A. Webbed neck
- B. Macroorchidism
- C. Ataxia
- D. Hemihyperplasia
- E. Hypogonadism (Correct Answer)
Klinefelter syndrome Explanation: ***Hypogonadism***
- The patient's presentation, including **hyperphagia**, **obesity**, developmental delay, and distinctive facial features (almond-shaped eyes, downturned mouth, poor muscle tone), is highly suggestive of **Prader-Willi Syndrome**.
- **Hypogonadism** (undescended testes in males, delayed puberty) is a classic feature of **Prader-Willi Syndrome** due to hypothalamic dysfunction, which also causes the voracious appetite.
*Webbed neck*
- A **webbed neck** is characteristic of **Turner Syndrome** (45, XO), which affects females and is associated with short stature, but not typically with the hyperphagia and obesity seen here.
- The patient is a male, making Turner Syndrome an unlikely diagnosis.
*Macroorchidism*
- **Macroorchidism** (enlarged testes) is a hallmark feature of **Fragile X Syndrome**, which is associated with intellectual disability and developmental delays.
- While fragile X syndrome involves developmental delay, it does not typically present with the extreme hyperphagia, obesity, and specific facial features described in the patient.
*Ataxia*
- **Ataxia** (lack of voluntary coordination of muscle movements) in conjunction with developmental delays can be seen in various neurological disorders such as **Friedreich's ataxia** or **cerebral palsy**.
- This symptom is not a primary or characteristic finding in Prader-Willi Syndrome, and the other described features point away from ataxia as the most likely additional finding.
*Hemihyperplasia*
- **Hemihyperplasia** (overgrowth of one side of the body) is associated with conditions like **Beckwith-Wiedemann Syndrome**, which also involves macroglossia and an increased risk of tumors.
- This finding is not typically associated with the constellation of symptoms (hyperphagia, obesity, intellectual disability, hypotonia) seen in Prader-Willi Syndrome.
Klinefelter syndrome US Medical PG Question 9: A 3-year-old girl is brought to the physician by her parents for complaints of breast development and pubic hair growth for the past 6 months. She has no significant birth or medical history. The temperature is 37.0°C (98.6°F), the pulse is 88/min, and the respirations are 20/min. Physical examination shows enlarged breasts at Tanner stage 3 and pubic hair at stage 2. Height and weight are in the normal range. On GnRH stimulation testing, a luteinizing hormone (LH) response of < 5 IU/L is detected. What is the most appropriate next step in diagnosis?
- A. Perform leuprolide stimulation test to measure testosterone
- B. Measure baseline estradiol levels and perform pelvic ultrasound (Correct Answer)
- C. Measure FSH levels to evaluate pituitary function
- D. Calculate LH:FSH ratio from previous GnRH test
- E. Repeat GnRH stimulation test to confirm LH response
Klinefelter syndrome Explanation: ***Measure baseline estradiol levels and perform pelvic ultrasound***
- This patient presents with **precocious puberty** (breast development and pubic hair at age 3). The **low LH response** (<5 IU/L) to GnRH stimulation confirms **peripheral (gonadotropin-independent) precocious puberty**.
- In peripheral precocious puberty, sex hormones are produced **autonomously** (independent of pituitary control), which **suppresses** the hypothalamic-pituitary-gonadal axis through negative feedback.
- The next step is to **identify the source** of autonomous sex hormone production. **Measuring estradiol levels** confirms elevated estrogen, and **pelvic ultrasound** evaluates for ovarian causes such as **ovarian cysts** or **tumors** (e.g., granulosa cell tumor), which are common causes of peripheral precocious puberty in girls.
- Other causes to consider include **McCune-Albright syndrome** (café-au-lait spots, polyostotic fibrous dysplasia) or exogenous estrogen exposure.
*Measure FSH levels to evaluate pituitary function*
- Measuring FSH is **not helpful** in this clinical context because the low LH response to GnRH stimulation **already indicates** that the pituitary is suppressed.
- In peripheral precocious puberty, both LH and FSH are **suppressed** due to negative feedback from peripherally produced sex hormones. Measuring FSH would simply confirm what we already know - that the pituitary axis is not activated.
- The priority is to find the **source** of the sex hormones, not to further characterize pituitary suppression.
*Perform leuprolide stimulation test to measure testosterone*
- Leuprolide is a **GnRH agonist** used to evaluate **central precocious puberty**, where the HPG axis is prematurely activated.
- This test is **not indicated** for peripheral precocious puberty, which has already been confirmed by the low LH response.
- Additionally, measuring testosterone would not be useful in a female patient presenting with estrogenic signs (breast development).
*Calculate LH:FSH ratio from previous GnRH test*
- The **LH:FSH ratio** is useful in diagnosing **central precocious puberty**, where an LH-predominant response (LH:FSH ratio >0.6-1.0) is characteristic.
- Since the LH response is already **low** (<5 IU/L), confirming peripheral precocious puberty, this ratio would not provide diagnostic value.
- The focus should be on investigating the **peripheral source** of sex hormones.
*Repeat GnRH stimulation test to confirm LH response*
- Repeating the GnRH stimulation test is **unnecessary** when the initial test provides clear results.
- The low LH response (<5 IU/L) definitively indicates peripheral precocious puberty, and repeating the test would only delay appropriate diagnostic workup for the underlying cause.
Klinefelter syndrome US Medical PG Question 10: A 5-year-old girl with Down syndrome presents with fatigue, pallor, and hepatosplenomegaly. Complete blood count shows WBC 45,000/μL with 80% blasts, hemoglobin 6.5 g/dL, and platelets 25,000/μL. Flow cytometry reveals blasts positive for CD19, CD10, and TdT. Cytogenetics show t(12;21) in addition to trisomy 21. Her parents ask about prognosis compared to children without Down syndrome. Synthesizing genetic and prognostic factors, what is the most accurate statement?
- A. Down syndrome is associated with worse prognosis in ALL due to increased treatment-related mortality
- B. The t(12;21) translocation negates any effect of Down syndrome on prognosis
- C. Down syndrome children with ALL have better outcomes than non-Down syndrome children with comparable cytogenetics (Correct Answer)
- D. Prognosis is identical to non-Down syndrome children when stratified by cytogenetics
- E. Down syndrome mandates reduced-intensity chemotherapy with consequently worse outcomes
Klinefelter syndrome Explanation: ***Down syndrome children with ALL have better outcomes than non-Down syndrome children with comparable cytogenetics***
- Children with **Down syndrome (Trisomy 21)** and **B-cell ALL** demonstrate increased sensitivity to **Methotrexate** due to altered folate metabolism, leading to higher intracellular levels of active metabolites.
- When treated with contemporary protocols, this population exhibits improved **event-free survival** and overall survival compared to their non-syndromic peers.
*Down syndrome is associated with worse prognosis in ALL due to increased treatment-related mortality*
- While patients with Down syndrome experience higher **treatment-related toxicity** (specifically infections and mucositis), this does not lead to a poorer overall prognosis compared to the general population.
- The enhanced **chemosensitivity** of the blasts typically outweighs the risks of increased clinical toxicity.
*The t(12;21) translocation negates any effect of Down syndrome on prognosis*
- The **t(12;21) ETV6-RUNX1** translocation is a favorable prognostic marker, but its presence works synergistically with the biological advantages conferred by **Trisomy 21**.
- Down syndrome remains an independent factor in predicting **pharmacodynamic response** to therapy and does not become irrelevant due to cytogenetics.
*Prognosis is identical to non-Down syndrome children when stratified by cytogenetics*
- This statement is incorrect because children with Down syndrome have unique **pharmacogenetic profiles** that distinguish their response from the general population.
- Their blasts are significantly more sensitive to specific chemotherapeutic agents, resulting in better **minimal residual disease (MRD)** clearance.
*Down syndrome mandates reduced-intensity chemotherapy with consequently worse outcomes*
- Standard protocols are generally maintained, although **leucovorin rescue** may be adjusted to manage **methotrexate toxicity** without sacrificing efficacy.
- Reducing chemotherapy intensity is not a standard requirement and would potentially lead to higher **relapse rates**, which is not the observed clinical trend.
More Klinefelter syndrome US Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
